Hyperlipidaemia in youth with type 1 diabetes: Are current guidelines clinically useful?
Authors' conclusion
Overall, our data indicate low adherence to international guidelines for dyslipidaemia screening and management.
Study context
- Population
- Paediatric patients diagnosed with T1D, Australian context
- Participants
- 335 patients
- Outcome
- Adherence to international consensus guidelines for dyslipidaemia screening, and trajectory and clinical management after diagnosis of dyslipidaemia
Main finding
As reported in the abstract
- Followed initial lipid screening guidelines
- 263 (78%)
- Mean interval of testing (vs recommended 5-year interval)
- 17 months (SD 8 months)
- ≥1 abnormal lipid test parameter
- 55% (n = 183/335)
- Mean age at diagnosis of dyslipidaemia
- 15.6 years (SD 2.0 years)
- Abnormal low-density lipoprotein-cholesterol (LDL-C) level
- 69 (25%, 69/280)
- LDL-C >3.4 mmol/L among abnormal LDL-C
- 15/69, 22%
- LDL-C >4.1 mmol/L among abnormal LDL-C
- 4/69, 6%
- Referred to a dietician among abnormal LDL-C
- 1 of 69
- Commenced on pharmacotherapy
- 0
Observational data: associations, not effects.
Original publication
Hyperlipidaemia in youth with type 1 diabetes: Are current guidelines clinically useful? Diabet Med. Published 1 July 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →